anjali shrivastava covers academics and administration. contact her at
.
.
.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
. nightlife: bot wednesdays, belfast - may 16 2018 [photos]
.
.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).